Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients With Non-Val30Met and Non-Val122Ile Hereditary Transthyretin Amyloidosis

Journal of Cardiovascular Translational Research - United States
doi 10.1007/s12265-015-9613-9

Related search